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PCOC is a national palliative care project funded by the  
Australian Government Department of Health www.pcoc.org.au 
 
About the Palliative Care Outcomes Collaboration  
 
The Palliative Care Outcomes Collaboration (PCOC) is a national program that utilises standardised clinical assessment tools to measure and benchmark patient 
outcomes in palliative care. Participation in PCOC is voluntary and can assist palliative care service providers to improve practice. This is achieved via the PCOC patient 
outcome improvement framework which is designed to: 
 provide clinicians with the tools to systematically assess individual patient experiences using validated clinical assessment tools, 
 define a common clinical language to streamline communication between palliative care providers, 
 facilitate the routine collection of national palliative care data to drive quality improvement through reporting and benchmarking,  
 provide service-to-service benchmarking reports and opportunities to discuss sector results at benchmarking workshops, and 
 support research using the PCOC longitudinal database (2006-2015). 
 
The PCOC dataset includes the clinical assessment tools: Palliative Care Phase, Palliative Care Problem Severity Score (PCPSS), Symptom Assessment Scale (SAS), 
Australia-modified Karnofsky Performance Status (AKPS) scale and Resource Utilisation Groups – Activities of Daily Living (RUG-ADL).  
 
PCOC has divided Australia into four zones for the purpose of engaging with palliative care service providers. Each zone is represented by a chief investigator from one of 
the collaborative centres. The four PCOC zones and their respective chief investigators are: 
 
 
Central Zone    Professor Kathy Eagar, Australian Health Services Research Institute, University of Wollongong 
North Zone        Professor Patsy Yates, Institute of Health and Biomedical Innovation, Queensland University of Technology 
South Zone        Professor David Currow, Department of Palliative and Supportive Services, Flinders University 
West Zone         Dr Claire Johnson, Cancer and Palliative Care Research and Evaluation Unit, University of WA 
 
Each zone is also represented by one or more quality improvement facilitators, whose role includes supporting services to participate in PCOC and facilitating ongoing 
service development and quality improvement. The national team, located within the Australian Health Services Research Institute at the University of Wollongong, 
coordinates the patient outcomes reporting, education program, and quality activities across the four zones.   
 
If you would like more information or have any queries about this report please contact  
your local quality improvement facilitator  
or contact the national office at pcoc@uow.edu.au or phone (02) 4221 4411. 
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Introduction 
 
The Palliative Care Outcomes Collaboration (PCOC) assists services to improve the quality of the palliative care they provide through the analysis and benchmarking of 
patient outcomes. In this patient outcome report, data submitted for the January to June 2015 period are summarised and patient outcomes benchmarked. The purpose 
of benchmarking is to drive palliative care service innovation and provide participating services with the opportunity to compare their service nationally. 
 
Patient outcomes are reported for a total of 19,220 patients, with 24,180 episodes of care and 55,991 palliative care phases. The information included in this report is 
determined by a data scoping method. See Appendix A for more information on the data included in this report. 
 
The national figures are based on information submitted by 100 services, of which: 
 59 are inpatient services. Inpatient services include patients who have been seen in designated palliative care beds as well as non-designated bed consultations. 
 28 are community services. These services include primarily patients seen in the community as well as some patients with ambulatory/clinic episodes. 
 13 are services with both inpatient and community settings. 
 
A full list of the services included in the national figures can be found at www.pcoc.org.au. 
 
 
 
 
  
Interpretation hint: 
Some tables throughout this report may be incomplete. This is because some items may not be applicable or it may be due to data quality issues. 
Please use the following key when interpreting the tables: 
na The item is not applicable. 
u The item was unavailable. 
s The item was suppressed due to insufficient data as there was less than 10 observations.  
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Section 1  Benchmark summary 
1.1 Australian Outcomes at a glance 
Table 1  Summary of outcome measures 1 to 3 by setting 
Outcome measure Description Benchmark 
Inpatient Community 
Score 
(%) 
Benchmark  
Met? 
Score 
(%) 
Benchmark  
Met? 
1. Time from date ready 
for care to episode start 
Benchmark 1:  
Patients episode commences on the day of, or the day after date ready for care 
90% 96.6 Yes 85.7 No 
2. Time in unstable 
phase 
Benchmark 2: 
Patients in the unstable phase for 3 days or less 
90% 86.3 No 76.7 No 
3. Change in pain 
 
Benchmark 3.1: PCPSS 
Patients with absent  or mild pain at phase start, remaining absent  or mild at phase end 
90% 90.9 Yes   84.4 No 
Benchmark 3.2: PCPSS 
Patients with moderate or severe pain at phase start, with absent or mild pain at phase end 
60% 59.8 No    53.5 No 
Benchmark 3.3: SAS 
Patients with absent  or mild distress from pain at phase start, remaining absent  or mild at phase end 
90% 88.9 No    81.5 No 
Benchmark 3.4: SAS 
Patients with moderate or severe distress from pain at phase start, with absent or mild at phase end 
60% 53.5 No    46.8 No 
 
Table 2  Summary of outcome measure 4: Average improvement on the 2014 baseline national average (X-CAS) 
Clinical Tool Description Average improvement on baseline Benchmark met? 
PCPSS 
  
  
  
Benchmark 4.1: Pain 0.02 Yes 
Benchmark 4.2: Other symptoms 0.04 Yes 
Benchmark 4.3: Family / carer 0.03 Yes 
Benchmark 4.4: Psychological / spiritual 0.05 Yes 
SAS 
  
  
  
Benchmark 4.5: Pain 0.00 Yes 
Benchmark 4.6: Nausea 0.02 Yes 
Benchmark 4.7: Breathing problems 0.07 Yes 
Benchmark 4.8: Bowel problems 0.04 Yes 
 
The benchmark for  
outcome measure 4 is zero. 
 
For more information on the outcome measures  
and benchmarks, see Section 2. 
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1.2 National benchmark profiles 
 
In this section, the national profiles for selected benchmarks are split by setting (inpatient or community) and presented graphically.  
The selected benchmarks included are: 
 Benchmark 1 Patients episode commences on the day of or the day after date ready for care 
 Benchmark 2 Patients in the unstable phase for 3 days or less 
 Benchmark 3.1 PCPSS: Patients with absent or mild pain at phase start, remaining absent or mild at phase end 
 Benchmark 3.2 PCPSS: Patients with moderate or severe pain at phase start, with absent or mild pain at phase end 
 Benchmark 3.3 SAS: Patients with absent or mild distress from pain at phase start, remaining absent or mild at phase end 
 Benchmark 3.4 SAS: Patients with moderate or severe distress from pain at phase start, with absent or mild distress from pain at phase end 
 
 
 
  Interpretation hint: 
The national profile graphs on the following pages allow services to see how they are performing in comparison to other palliative care services participating in 
PCOC. In each graph, the shaded region describes the national profile for that outcome measure. 
The red line on the graph indicates the benchmark for that outcome measure. 
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Outcome measure 1 – Time from date ready for care to episode start 
Figure 1  Percentage of patients with episodes that commenced on the day of, or the day after date ready for care 
 
Outcome measure 2 – Time in unstable phase 
Figure 2  Percentage of patients in the unstable phase for 3 days or less 
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Outcome measure 3 – Change in pain 
Figure 3  PCPSS: Percentage of patients with absent or mild pain at phase start, remaining absent or mild at phase end 
 
Figure 4  PCPSS: Percentage of patients with moderate or severe pain at phase start, with absent or mild pain at phase end 
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Figure 5  SAS: Percentage of patients with absent or mild distress from pain at phase start, remaining absent or mild at phase end 
 
Figure 6  SAS: Percentage of patients with moderate or severe distress from pain at phase start, with absent or mild distress from pain at phase end 
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Section 2  Outcome measures in detail 
 
2.1 Outcome measure 1 – Time from date ready for care to episode start 
Time from date ready for care to episode start reports responsiveness of palliative care services to patient needs. This benchmark was set following feedback and 
subsequent consultation with PCOC participants. Service providers acknowledge that, whilst there is wide variation in the delivery of palliative care across the country, 
access to palliative care should be measured based on patient need rather than service availability. As a result, services operating five days a week (Monday to Friday) 
are not distinguished from services operating seven days a week (all services are being benchmarked together). 
Benchmark 1: This measure relates to the time taken for an episode to commence following the date the patient is available and ready to receive palliative 
care. To meet the benchmark for this measure, at least 90% of patients must have their episode commence on the day of, or the day following 
date ready for care. 
 
Table 3  Time from date ready for care to episode start by setting 
Time (in days) 
Inpatient Community 
N % N % 
Same day 10,597 91.8 8,248 80.3 
Following day 545 4.7 553 5.4 
2-7 days 351 3.0 1,087 10.6 
8-14 days 38 0.3 224 2.2 
Greater than 14 days 9 0.1 156 1.5 
Average 1.1 na 2.1 na 
Median 1 na 1 na 
Note: Only episodes that started in this reporting period have been included in the table. Episodes where date ready for care was not recorded are excluded from the table. In addition, all  
records where time from date ready for care to episode start was greater than 90 days were considered to be atypical and were assumed to equal 90 days for the purpose of calculating the average  
and median time. 
 
 
 
 
 
Interpretation hint:  
Outcome measure 1 only includes episodes that have commenced in the reporting period. As a result, the number of episodes included in the calculation of this 
benchmark may not match the number of episodes in Appendix A. For more information on data scoping methods, see Appendix C. 
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Figure 7  Trends in benchmark 1: Patients with episodes that commenced on the day of, or the day after date ready for care by setting 
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2.2 Outcome measure 2 – Time in unstable phase 
The unstable phase type, by nature of its definition, alerts clinical staff to the need for urgent changes to the patient’s plan of care or that emergency intervention is 
required. Those patients assessed to be in the unstable phase require intense review for a short period of time.  
An unstable phase is triggered if: 
 a patient experiences a new, unanticipated problem, and / or 
 a patient experiences a rapid increase in the severity of an existing problem, and / or 
 a patient’s family / carers experience a sudden change in circumstances that adversely impacts the patient’s care. 
The patient moves out of the unstable phase in one of two ways: 
 A new plan of care has been put in place, has been reviewed and does not require any additional changes. This does not necessarily mean that the symptom / crisis 
has been fully resolved. However, the clinical team will have a clear diagnosis and a plan for the patient’s care. In this situation, the patient will move to either the 
stable or deteriorating phase. 
 The patient is likely to die within a matter of days. In this situation, the patient will be moved into the terminal phase. 
Benchmark 2: This benchmark relates to the time that a patient spends in the unstable phase. To meet this benchmark, at least 90% of unstable phases must 
last for 3 days or less. 
 
Table 4  Time in unstable phase by setting 
Time in unstable phase 
Inpatient Community 
N % N % 
Same day 233 3.4 849 23.4 
1 day 3,277 47.2 1,239 34.2 
2 days 1,724 24.8 441 12.2 
3 days 763 11.0 252 7.0 
4-5 days 595 8.6 236 6.5 
6-7 days 196 2.8 187 5.2 
8-14 days 129 1.9 203 5.6 
Greater than 14 days 28 0.4 218 6.0 
Total 6,945 100.0 3,625 100.0 
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Figure 8  Trends in benchmark 2: Patients in the unstable phase for 3 days or less by setting 
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2.3 Outcome measure 3 – Change in pain 
The Palliative Care Problem Severity Score (PCPSS) and Symptom Assessment Scale (SAS) provide two different perspectives of pain. The PCPSS is clinician rated and 
measures the severity of pain as a clinical problem while the SAS is patient rated and measures distress caused by pain. There are two benchmarks related to each tool: 
one relating to patients with an absent or mild score, and the other relating to patients with a moderate or severe score. Phase records must have valid start and end 
scores for the PCPSS and / or SAS clinical assessment tools to be included in the benchmarks. 
 
 
 
 
 
 
 
 
Benchmark 3.1: This benchmark relates to patients who have absent or mild pain at the start of their phase of palliative care, as rated via the PCPSS clinical tool. 
To meet this benchmark, 90% of these phases must end with the patient still experiencing only absent or mild pain. 
 
Benchmark 3.2: This benchmark relates to patients who have moderate or severe pain at the start of their phase of palliative care, as rated via the PCPSS clinical 
tool. To meet this benchmark, 60% of these phases must end with the patient’s pain reduced to being absent or mild. 
 
Benchmark 3.3: This benchmark relates to patients who have absent or mild distress from pain at the start of their phase of palliative care, as rated via the SAS 
clinical tool. To meet this benchmark, 90% of these phases must end with the patient still experiencing only absent or mild distress from pain. 
 
Benchmark 3.4: This benchmark relates to patients who have moderate or severe distress from pain at the start of their phase of palliative care, as rated via the 
SAS clinical tool. To meet this benchmark, 60% of these phases must end with the patient’s distress from pain reduced to absent or mild. 
 
Table 5  Summary of outcome measure 3 
Benchmarks: change in pain 
Inpatient Community 
N* % N* % 
Benchmark 3.1: PCPSS (severity) 16,578 90.9 15,665 84.4 
Benchmark 3.2: PCPSS (severity) 5,399 59.8 3,992 53.5 
Benchmark 3.3: SAS (distress) 14,451 88.9 14,633 81.5 
Benchmark 3.4: SAS (distress) 6,419 53.5 5,255 46.8 
*Total number of phases included in this benchmark. 
  
   Scores for SAS 
   0 = absent distress 
   1-3 = mild distress 
   4-7 = moderate distress 
   8-10 = severe distress 
Scores for PCPSS 
0 absent 
1 mild 
2 moderate 
3 severe 
Interpretation hint: 
This outcome measure should be viewed in conjunction with Table 28 to  
Table 31 and Appendix B. 
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Figure 9  Trends in benchmark 3.1: Patients with absent or mild pain at phase start, remaining absent or mild at phase end by setting 
 
 
Figure 10 Trends in benchmark 3.2: Patients with moderate or severe pain at phase start, with absent or mild at phase end by setting 
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Figure 11  Trends in benchmark 3.3: Patients with absent or mild distress from pain at phase start, remaining absent or mild at phase end by setting 
 
 
Figure 12  Trends in benchmark 3.4: Patients with moderate or severe distress from pain at phase start, with absent or mild distress from pain at phase end by setting 
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2.4 Outcome measure 4 – Change in symptoms relative to the baseline national average (X-CAS) 
Outcome measure 4 includes a suite of case-mix adjusted scores used to compare the change in symptoms for similar patients i.e. patients in the same phase who 
started with the same level of symptom. Eight symptoms are included in this report and the baseline reference period is January to June 2014. The suite of benchmarks 
included in outcome measure 4 are generally referred to as X-CAS – CAS standing for Case-mix Adjusted Score, and the X to represent that multiple symptoms are 
included. As X-CAS looks at change in symptom, they are only able to be calculated on phases which ended in phase change or discharge (as the phase end scores are 
required to determine the change). 
 
Table 6  Summary of outcome measure 4 
Clinical Tool Benchmark: Symptom X-CAS 
N phases included 
in measure 
N phases at or 
above the baseline 
% phases at or 
above the baseline  
PCPSS 
(severity) 
4.1: Pain 0.02 41,634 24,461 58.8 
4.2: Other symptoms 0.04 40,844 26,307 64.4 
4.3: Family / carer 0.03 40,854 25,423 62.2 
4.4: Psychological / spiritual 0.05 41,465 22,401 54.0 
SAS 
(distress) 
4.5: Pain 0.00 40,758 25,154 61.7 
4.6: Nausea 0.02 40,240 33,123 82.3 
4.7: Breathing Problems 0.07 40,013 28,503 71.2 
4.8: Bowel Problems 0.04 39,831 28,751 72.2 
 
 
 
Interpretation hint: 
The X-CAS measures are calculated relative to a baseline reference period (currently January to June 2014). As a result: 
If X-CAS is greater than 0 then on average, the patients’ change in symptom was better than similar patients in the baseline reference period.  
If X-CAS is equal to 0 then on average, the patients’ change in symptom was about the same as similar patients in the baseline reference period. 
If X-CAS is less than 0 then on average, the patients’ change in symptom was worse than similar patients in the baseline reference period. 
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Figure 13  Trends in outcome measure 4 – Palliative Care Problem Severity Score (PCPSS) 
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Figure 14  Trends in outcome measure 4 – Symptom Assessment Scale (SAS) 
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Section 3  Descriptive analysis 
 
This section provides descriptive information of the data submitted at each of the three levels – patient, episode and phase. 
 
Patient level information describes demographics such as Indigenous status, sex, preferred language and country of birth. This information about the patient provides a 
context to the episode and phase level information and enhances the meaningfulness of patient outcomes. 
 
Episode level information describes the setting of palliative care service provision. It also includes information relating to the facility or organisation that has referred the 
patient, how an episode starts and ends, and the setting in which the patient died. 
 
Phase level information describes the clinical condition of the patient during the episode, using five clinical assessment tools. These are phase of illness, the patient’s 
functional status and performance, pain and other common symptoms, the patient’s psychological / spiritual and family / carer domain. 
 
  
     
 National Report on Patient Outcomes in Palliative Care in Australia, January - June 2015 18 
3.1 Profile of palliative care patients 
PCOC defines a patient as a person for whom a palliative care service accepts responsibility for assessment and / or treatment as evidenced by the existence of a medical 
record. Family and carers are included in this definition if interventions relating to them are recorded in the patient medical record. 
Table 7 shows the Indigenous status for patients nationally. 
 
Table 7  Indigenous status  
Indigenous status N % 
Aboriginal but not Torres Strait Islander origin 205 1.1 
Torres Strait Islander but not Aboriginal origin 17 0.1 
Both Aboriginal and Torres Strait Islander origin 13 0.1 
Neither Aboriginal nor Torres Strait Islander origin 18,587 96.7 
Not stated / inadequately described 398 2.1 
Total 19,220 100.0 
 
Table 8 shows the breakdown of deaths for patients nationally for the reporting period. All inpatient deaths are reported in the hospital category while the community 
deaths are reported in the private residence and residential aged care facility categories. 
Table 8  Place of death 
Place of death N % 
Private residence 1,870 19.8 
Residential aged care facility 695 7.4 
Hospital 6,720 71.2 
Not stated / inadequately described 150 1.6 
Total 9,435 100.0 
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The following two tables show the country of birth and the preferred language respectively. To allow for comparison with the broader Australian community the list of 
country of birth in Table 9 is in descending order of the most frequent country of birth according to the 2006 Census (e.g. Italy was the fifth most common country of 
birth in the 2006 Census). The same approach has been taken with Table 10 (e.g. Greek was the third most frequently spoken language in the 2006 census). All other 
countries and languages have been grouped together to form the categories ‘All other countries’ and ‘All other languages’ respectively.  
 
Table 9  Country of birth  
Country of birth N % 
Australia 11,998 62.4 
England 1,367 7.1 
New Zealand 357 1.9 
China 240 1.2 
Italy 757 3.9 
Vietnam 152 0.8 
India 143 0.7 
Scotland 261 1.4 
Philippines 84 0.4 
Greece 398 2.1 
Germany 233 1.2 
South Africa 83 0.4 
Malaysia 66 0.3 
Netherlands 194 1.0 
Lebanon 107 0.6 
All other countries 2,500 13.0 
Not stated / inadequately described 280 1.5 
Total 19,220 100.0 
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 Table 10  Preferred language  
Preferred language N % 
English 17,250 89.8 
Italian 366 1.9 
Greek 267 1.4 
Chinese(a) 216 1.1 
Arabic(b) 130 0.7 
Vietnamese(c) 71 0.4 
Spanish / Portuguese(d) 46 0.2 
Filipino / Indonesian(e) 17 0.1 
German(f) 30 0.2 
Hindi(g) 29 0.2 
Croatian / Macedonian(h) 126 0.7 
Korean 15 0.1 
Turkish(i) 35 0.2 
Polish(j) 25 0.1 
Maltese 18 0.1 
All other languages 416 2.2 
Not stated / inadequately described 163 0.8 
Total 19,220 100.0 
(a) Chinese includes: Cantonese, Hakka, Mandarin, Wu and Min Nan;  (b) Middle Eastern Semitic Languages includes: Hebrew, Assyrian Neo-Aramaic, Chaldean Neo-Aramaic, Mandaean (Mandaic); (c) Mon-
Khmer includes: Khmer, Mon; (d) Iberian Romance includes: Catalan;  (e) Southeast Asian Austronesian Languages includes: Bisaya, Cebuano, IIokano,  Malay, Tetum, Timorese, Tagalog, Acehnese, 
Balinese, Bikol, Iban, Ilonggo (Hiligaynon), Javanese, Pampangan; (f) German and Related Languages include: Letzeburgish, Yiddish; (g) Indo-Aryan includes: Bengali, Gujarati, Konkani, Marathi, Nepali, 
Punjabi, Sindhi,  Sinhalese, Urdu, Assamese, Dhivehi, Kashmiri, Oriya, Fijian Hindustani; (h) South Slavic includes: Bosnian, Bulgarian, Serbian, Slovene; (i) Turkic includes: Azeri, Tatar, Turkmen, Uygur, Uzbek; 
(j) West Slavic includes: Czech, Slovak 
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Table 11 and Table 12 present a breakdown of malignant and non-malignant diagnosis for the patients at the national level. The primary diagnosis is the principal life 
limiting illness responsible for the patient requiring palliative care. 
The primary diagnosis was not stated for 80 (0.4%) patients nationally. 
 
Table 11  Primary diagnosis - malignant 
Primary diagnosis N 
% malignant 
diagnosis 
% all diagnosis 
Bone and soft tissue 238 1.6 1.2 
Breast  1,176 7.9 6.1 
CNS 344 2.3 1.8 
Colorectal  1,644 11.0 8.6 
Other GIT 1,401 9.4 7.3 
Haematological 963 6.4 5.0 
Head and neck 826 5.5 4.3 
Lung 3,340 22.3 17.4 
Pancreas  938 6.3 4.9 
Prostate 1,003 6.7 5.2 
Other urological 593 4.0 3.1 
Gynaecological 740 4.9 3.9 
Skin  589 3.9 3.1 
Unknown primary  372 2.5 1.9 
Other primary malignancy 526 3.5 2.7 
Malignant – not further defined 259 1.7 1.3 
All malignant 14,952 100.0 77.8 
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Table 12  Primary diagnosis - non-malignant 
Primary diagnosis N 
% non-malignant 
diagnosis 
% all diagnosis 
Cardiovascular disease 733 17.5 3.8 
HIV / AIDS  6 0.1 0.0 
End stage kidney disease 392 9.4 2.0 
Stroke 282 6.7 1.5 
Motor neurone disease 207 4.9 1.1 
Alzheimer’s dementia 148 3.5 0.8 
Other dementia 237 5.7 1.2 
Other neurological disease 335 8.0 1.7 
Respiratory failure  674 16.1 3.5 
End stage liver disease 171 4.1 0.9 
Diabetes and its complications 16 0.4 0.1 
Sepsis 116 2.8 0.6 
Multiple organ failure 91 2.2 0.5 
Other non-malignancy  646 15.4 3.4 
Non-malignant – not further defined 134 3.2 0.7 
All non-malignant 4,188 100.0 21.8 
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3.2 Profile of palliative care episodes 
An episode of care is a period of contact between a patient and a palliative care service that is provided by one palliative care service and occurs in one setting – for the 
purposes of this report, either as an inpatient or community patient.  
 
An episode of palliative care starts on the date when the comprehensive palliative care assessment is undertaken and documented using the five clinical assessment 
tools.  
 
An episode of palliative care ends when: 
 the patient is formally separated from the current setting of care (e.g. from community to inpatient) or 
 the patient dies or 
 the principal clinical intent of the care changes and the patient is no longer receiving palliative care. 
 
Table 13 below presents the number and percentage of episodes by age group and sex. Age has been calculated as at the beginning of each episode. 
 
Table 13  Age group by sex 
Age group 
Male Female 
N % N % 
< 15 36 0.3 26 0.2 
15 - 24 31 0.2 26 0.2 
25 - 34 106 0.8 90 0.8 
35 - 44 278 2.2 390 3.4 
45 - 54 725 5.7 926 8.1 
55 - 64 2,009 15.8 1,786 15.5 
65 - 74 3,313 26.1 2,669 23.2 
75 - 84 3,750 29.6 3,008 26.2 
85+ 2,440 19.2 2,566 22.3 
Not stated / inadequately described 0 0.0 0 0.0 
Total 12,688 100.0 11,487 100.0 
Note: Records where sex was not stated or inadequately described are excluded from the table. 
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Referral source refers to the facility or organisation from which the patient was referred for each episode of care. Table 14 presents referral source by setting.   
 
Table 14  Referral source by setting 
Referral source 
Inpatient Community 
N % N % 
Public hospital 7,216 57.9 6,559 56.0 
Private hospital 1,015 8.1 1,157 9.9 
Outpatient clinic 98 0.8 66 0.6 
General medical practitioner 418 3.4 1,714 14.6 
Specialist medical practitioner 567 4.5 467 4.0 
Community-based palliative care agency 2,767 22.2 105 0.9 
Community-based service 49 0.4 210 1.8 
Residential aged care facility 54 0.4 788 6.7 
Self, carer(s), family or friends 148 1.2 423 3.6 
Other 115 0.9 193 1.6 
Not stated / inadequately described 17 0.1 34 0.3 
Total  12,464 100.0 11,716 100.0 
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Table 15 provides a summary of the time between referral to first contact by setting of care. The time from referral to first contact is calculated as the time from the date 
of referral received to either the date of first contact (if provided) or the episode start date. 
 
 
Table 15  Referral to first contact by setting 
Time (in days) 
Inpatient Community 
N % N % 
Same day or following day 11,587 94.0 6,201 52.9 
2-7 days 607 4.9 3,930 33.5 
8-14 days 69 0.6 912 7.8 
Greater than 14 days 66 0.5 671 5.7 
Average 1.2 na 2.8 na 
Median 1 na 1 na 
Note: Episodes where referral date was not recorded are excluded from the table. In addition, all records where time from referral to first contact was greater than 90 days were considered to be atypical  
and were assumed to equal 90 days for the purpose of calculating the average and median time.  
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Table 16 gives a summary of the episode length and Table 17 details the length of episode by setting. The length of episode is calculated as the number of days between 
the episode start date and the episode end date. Bereavement phases are excluded from the calculation and episodes that remain open at the end of the reporting 
period (and hence do not have an episode end date) are also excluded. 
 
Table 16  Length of episode (in days) summary by setting 
Length of episode Inpatient Community 
Average length of episode 10.9 38.3 
Median length of episode 6.0 27.0 
Note: Records where length of episode was greater than 180 days were considered to be atypical and are excluded 
from the average calculations. Only episodes ending during the reporting period are included. 
 
 
Table 17  Length of episode (in days) by setting 
Length of episode 
Inpatient Community 
N % N % 
Same day 757 6.2 416 4.0 
1-2 days 2,322 19.0 740 7.1 
3-4 days 1,837 15.0 573 5.5 
5-7 days 1,998 16.3 803 7.7 
8-14 days 2,544 20.8 1,260 12.0 
15-21 days 1,151 9.4 950 9.1 
22-30 days 741 6.1 918 8.8 
31-60 days 683 5.6 1,812 17.3 
61-90 days 139 1.1 926 8.8 
Greater than 90 days 68 0.6 2,077 19.8 
Total 12,240 100.0 10,475 100.0 
Note: Only episodes ending during the reporting period are included.  
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Table 18  How episodes start – inpatient setting 
Episode start mode N % 
Admitted from community* 7,274 58.4 
Admitted from another hospital 3,156 25.3 
Admitted from acute care in another ward 1,721 13.8 
Change from acute care to palliative care – same ward 206 1.7 
Other** 100 0.8 
Not stated / inadequately described 7 0.1 
Total 12,464 100.0 
* includes: admitted from usual accommodation, admitted from other than usual accommodation. 
** includes: change of sub-acute/non-acute care type and other categories. 
 
Table 19  How episodes end – inpatient setting  
Episode end mode N % 
Discharged to community* 4,285 35.0 
Discharged to another hospital 749 6.1 
Death 6,720 54.9 
Change from palliative care to acute care** 59 0.5 
Change in sub-acute care type 57 0.5 
End of consultative episode – inpatient episode ongoing 260 2.1 
Other 100 0.8 
Not stated / inadequately described 10 0.1 
Total 12,240 100.0 
Note: Only episodes ending during the reporting period are included. 
* includes: discharged to usual accommodation, discharged to other than usual accommodation. 
** includes: change from palliative care to acute care – different ward, change from palliative care to acute care – same ward. 
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Table 20  How episodes start – community setting 
Episode start mode N % 
Admitted from inpatient palliative care 4,150 35.4 
Other* 7,505 64.1 
Not stated / inadequately described 61 0.5 
Total 11,716 100.0 
*includes: patient was not transferred from being an overnight patient. 
 
Table 21  How episodes end – community setting 
Episode end mode N % 
Admitted for inpatient palliative care 3,166 30.2 
Admitted for inpatient acute care 2,902 27.7 
Admitted to another palliative care service 180 1.7 
Admitted to primary health care 252 2.4 
Discharged / case closure 1,079 10.3 
Death 2,715 25.9 
Other 164 1.6 
Not stated / inadequately described 17 0.2 
Total 10,475 100.0 
Note: Only episodes ending during the reporting period are included. 
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3.3 Profile of palliative care phases 
The palliative care phase type describes the stage of the patient’s illness and provides a clinical indication of the level of care a patient requires. The palliative care phase 
is determined by a holistic clinical assessment which considers the needs of the patients and their family and carers. A patient may move back and forth between the 
stable, unstable, deteriorating and terminal phase types and these may occur in any sequence. See Appendix D for more information on the definition of palliative care 
phase. 
 
The clinical assessments are assessed daily (or at each visit) and are reported on admission, when the phase changes and at discharge. 
 
Table 22  Number of phases by phase type and setting 
Phase type 
Inpatient Community 
N % N % 
Stable                            7,474 25.4 9,994 37.7 
Unstable                          6,945 23.6 3,625 13.7 
Deteriorating                     9,150 31.1 10,802 40.7 
Terminal                          5,890 20.0 2,111 8.0 
Total 29,459 100.0 26,532 100.0 
Note: Bereavement phases have been excluded due to inconsistent data collection and bereavement practices.  
Bereavement phases are not included in the total phases count. 
 
Table 23  Average phase length (in days) by phase type and setting 
Phase type Inpatient Community 
Stable                            7.3 20.9 
Unstable                          2.2 4.1 
Deteriorating                     5.4 12.9 
Terminal                          2.1 3.0 
Note: Phase records where phase length was greater than 90  
days were considered to be atypical and are excluded from the average calculations. 
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Table 24 presents information relating to the manner in which stable phases ended. A stable phase will end if a patient moves into a different phase (phase change), is 
discharged or dies. Figure 15 summarises the movement of patients out of the stable phase for the inpatient and community settings. This movement from one phase to 
another is referred to as phase progression and is derived by PCOC.  
Similar information is presented for the unstable (Table 25, Figure 16), deteriorating (Table 26, Figure 17) and terminal (Table 27, Figure 18) phases on the following 
pages. 
Table 24  How stable phases end – by setting 
How stable phases end 
Inpatient Community 
N % N % 
Patient moved into another phase                 3,825 51.2 6,461 64.6 
Discharge / case closure            3,559 47.6 3,194 32.0 
Died                              86 1.2 301 3.0 
Not stated / inadequately described 4 0.1 38 0.4 
Total 7,474 100.0 9,994 100.0 
 
Figure 15  Stable phase progression 
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Table 25  How unstable phases end – by setting 
How unstable phases end 
Inpatient Community 
N % N % 
Patient moved into another phase                       6,296 90.7 2,400 66.2 
Discharge / case closure            489 7.0 1,157 31.9 
Died                              156 2.2 65 1.8 
Not stated / inadequately described 4 0.1 3 0.1 
Total 6,945 100.0 3,625 100.0 
 
 
 
Figure 16  Unstable phase progression 
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Table 26  How deteriorating phases end – by setting 
How deteriorating phases end 
Inpatient Community 
N % N % 
Patient moved into another phase      6,834 74.7 6,853 63.4 
Discharge / case closure  1,353 14.8 3,121 28.9 
Died  958 10.5 794 7.4 
Not stated / inadequately described 5 0.1 34 0.3 
Total 9,150 100.0 10,802 100.0 
 
 
 
 
Figure 17  Deteriorating phase progression 
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Table 27  How terminal phases end – by setting 
How terminal phases end 
Inpatient Community 
N % N % 
Patient moved into another phase               265 4.5 340 16.1 
Discharge / case closure 103 1.7 198 9.4 
Died 5,516 93.7 1,567 74.2 
Not stated / inadequately described 6 0.1 6 0.3 
Total 5,890 100.0 2,111 100.0 
 
 
 
 
Figure 18  Terminal phase progression 
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The Palliative Care Problem Severity Score (PCPSS) is a clinician rated screening tool to assess the overall severity of problems within four key palliative care domains 
(pain, other symptoms, psychological / spiritual and family / carer). The ratings are: 0 - absent, 1 - mild, 2 - moderate and 3 - severe.  
Table 28 and Table 29 show the percentage scores for the inpatient and community settings respectively. Alternative graphical representations of PCPSS profile by phase 
type can be found in Appendix B. 
 
Table 28  Profile of PCPSS at beginning of phase by phase type – inpatient setting (percentages) 
Phase type Problem severity Absent Mild Moderate Severe 
Stable                            
Pain                    48.6 37.6 11.6 2.2 
Other symptoms          29.1 51.2 16.9 2.8 
Psychological / spiritual 39.6 48.8 10.0 1.6 
Family / carer            43.0 44.3 10.5 2.3 
Unstable                          
Pain                    31.6 32.0 24.8 11.7 
Other symptoms          16.1 36.1 35.1 12.8 
Psychological / spiritual 27.5 45.4 21.3 5.8 
Family / carer            30.0 42.3 21.3 6.3 
Deteriorating                     
Pain                    39.0 36.6 19.0 5.4 
Other symptoms          18.4 41.9 31.8 7.9 
Psychological / spiritual 30.0 47.6 18.5 3.9 
Family / carer            29.4 42.9 21.9 5.8 
Terminal                          
Pain                    51.2 31.7 13.3 3.9 
Other symptoms          37.1 35.1 20.1 7.8 
Psychological / spiritual 53.4 32.6 10.8 3.2 
Family / carer            26.0 38.6 25.3 10.0 
 
  
     
 National Report on Patient Outcomes in Palliative Care in Australia, January - June 2015 35 
 
Table 29  Profile of PCPSS at beginning of phase by phase type –community setting (percentages) 
Phase type Problem severity Absent Mild Moderate Severe 
Stable                            
Pain                    40.8 51.4 7.3 0.6 
Other symptoms          16.1 66.5 16.1 1.3 
Psychological / spiritual 30.4 59.3 9.4 0.9 
Family / carer            30.6 54.0 13.7 1.6 
Unstable                          
Pain                    18.7 29.8 33.9 17.5 
Other symptoms          5.0 28.0 49.6 17.4 
Psychological / spiritual 12.4 46.5 34.0 7.1 
Family / carer            11.9 37.1 41.1 9.9 
Deteriorating                     
Pain                    29.2 49.3 19.0 2.4 
Other symptoms          8.3 50.7 37.1 4.0 
Psychological / spiritual 19.1 59.0 19.9 2.0 
Family / carer            17.4 51.3 27.3 3.9 
Terminal                          
Pain                    37.6 43.3 16.0 3.1 
Other symptoms          23.4 43.6 26.4 6.6 
Psychological / spiritual 43.6 40.8 13.0 2.6 
Family / carer            11.4 43.2 36.7 8.7 
 
 
The Symptom Assessment Scale (SAS) is a patient rated (or proxy) assessment tool and reports a level of distress using a numerical rating scale from 0 - no distress to 10 - 
worst possible distress. The SAS reports on distress from seven symptoms, these being difficulty sleeping, appetite problems, nausea, bowel problems, breathing 
problems, fatigue and pain. It provides a clinical picture of these seven symptoms from the patient’s perspective. The SAS scores are grouped in Table 30 and Table 31 on 
the following pages using the same categories as the PCPSS i.e. absent (0), mild (1-3), moderate (4-7) and severe (8-10). Alternative graphical representations of the SAS 
profile by phase type can be found in Appendix B. 
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 Table 30  Profile of SAS scores at beginning of phase by phase type – inpatient setting (percentages) 
Phase type Symptom distress 0 (Absent) 1-3 (Mild) 4-7 (Moderate) 8-10 (Severe) 
Stable                            
Difficulty sleeping 69.4 17.1 11.1 2.5 
Appetite problems 58.0 22.3 16.6 3.1 
Nausea 80.3 12.4 6.2 1.1 
Bowel problems 63.6 20.6 12.9 2.9 
Breathing problems 66.4 17.6 12.6 3.4 
Fatigue 31.1 26.6 35.2 7.1 
Pain 46.6 31.3 19.4 2.8 
Unstable                          
Difficulty sleeping 59.0 18.3 17.0 5.7 
Appetite problems 45.3 21.5 25.2 8.0 
Nausea 68.0 14.2 13.2 4.6 
Bowel problems 53.7 20.9 18.4 7.0 
Breathing problems 57.8 17.1 17.6 7.5 
Fatigue 23.7 19.9 41.3 15.1 
Pain 32.2 26.8 29.3 11.6 
Deteriorating                     
Difficulty sleeping 72.4 13.9 11.3 2.4 
Appetite problems 55.0 19.4 19.5 6.1 
Nausea 77.7 10.8 8.8 2.7 
Bowel problems 62.1 19.8 14.2 3.9 
Breathing problems 59.1 17.7 16.9 6.3 
Fatigue 30.3 17.7 37.9 14.1 
Pain 39.9 30.0 24.3 5.8 
Terminal                          
Difficulty sleeping 92.1 3.8 3.2 0.9 
Appetite problems 89.8 3.9 4.0 2.3 
Nausea 94.1 3.0 2.3 0.6 
Bowel problems 85.7 7.9 5.1 1.4 
Breathing problems 71.2 12.3 11.6 4.9 
Fatigue 75.8 5.9 10.4 7.8 
Pain 59.5 22.4 15.1 3.0 
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Table 31  Profile of SAS scores at beginning of phase by phase type –community setting (percentages) 
Phase type Symptom distress 0 (Absent) 1-3 (Mild) 4-7 (Moderate) 8-10 (Severe) 
Stable                            
Difficulty sleeping 63.2 26.5 9.4 0.9 
Appetite problems 49.2 33.4 15.1 2.3 
Nausea 80.4 15.8 3.4 0.5 
Bowel problems 66.4 25.8 6.8 1.0 
Breathing problems 54.3 30.6 13.3 1.8 
Fatigue 15.1 35.7 43.9 5.3 
Pain 43.8 42.3 12.6 1.2 
Unstable                          
Difficulty sleeping 43.0 26.7 24.2 6.1 
Appetite problems 32.2 26.8 30.9 10.0 
Nausea 60.3 18.7 15.2 5.8 
Bowel problems 51.2 26.8 16.8 5.3 
Breathing problems 44.9 28.1 20.7 6.3 
Fatigue 8.9 20.8 52.6 17.8 
Pain 20.2 23.9 37.7 18.2 
Deteriorating                     
Difficulty sleeping 57.4 26.9 13.9 1.7 
Appetite problems 39.8 32.4 23.0 4.8 
Nausea 72.8 19.0 7.2 1.1 
Bowel problems 60.3 26.9 11.1 1.6 
Breathing problems 47.9 30.7 18.7 2.6 
Fatigue 12.2 23.0 52.3 12.4 
Pain 33.2 39.5 24.0 3.3 
Terminal                          
Difficulty sleeping 75.8 13.3 9.0 1.9 
Appetite problems 79.0 7.5 6.2 7.3 
Nausea 83.9 10.8 4.6 0.7 
Bowel problems 73.2 18.0 7.8 1.0 
Breathing problems 55.7 24.0 16.1 4.2 
Fatigue 58.4 7.0 15.6 19.0 
Pain 40.2 35.0 21.3 3.5 
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The Australia-modified Karnofsky Performance Status (AKPS) is a measure of the patient’s overall performance status or ability to perform their activities of daily living. It 
is a single score between 0 and 100 assigned by a clinician based on observations of a patient’s ability to perform common tasks relating to activity, work and self-care. 
Table 32 shows the data for the AKPS at phase start. 
Table 32  Australia-modified Karnofsky Performance Status (AKPS) at phase start by setting 
AKPS  assessment 
Inpatient Community 
N % N % 
10 - Comatose or barely rousable 3,099 10.5 915 3.4 
20 - Totally bedfast and requiring extensive nursing care 6,617 22.5 2,569 9.7 
30 - Almost completely bedfast 3,735 12.7 1,906 7.2 
40 - In bed more than 50% of the time 5,608 19.0 3,438 13.0 
50 - Requires considerable assistance 4,971 16.9 6,369 24.0 
60 - Requires occasional assistance 3,053 10.4 6,553 24.7 
70 - Cares for self 657 2.2 3,168 11.9 
80 - Normal activity with effort 209 0.7 741 2.8 
90 - Able to carry on normal activity; minor signs or symptoms 76 0.3 135 0.5 
100 - Normal; no complaints; no evidence of disease 2 0.0 11 0.0 
Not stated/inadequately described 1,432 4.9 727 2.7 
Total 29,459 100.0 26,532 100.0 
 
The Resource Utilisation Groups – Activities of Daily Living (RUG-ADL) consists of four items (bed mobility, toileting, transfers and eating) and assesses the level of 
functional dependence. The RUG-ADL are assessed daily (or at each visit) and are reported on admission, when the phase changes and at discharge. Figure 19 and Figure 
20 on the following two pages summarise the total RUG-ADL at the beginning of each phase for inpatients and community patients. The total score on the RUG-ADL 
ranges from a minimum of 4 (lowest level of functional dependency) to a maximum of 18 (highest level of functional dependency). 
AKPS & RUG-ADL can be used together to provide a profile of both patient dependency, equipment requirements, need for allied health referrals and carer 
burden/respite requirements.  
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Figure 19  Total RUG-ADL at beginning of phase by phase type – inpatient setting 
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Figure 20  Total RUG-ADL at beginning of phase by phase type – community setting 
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Appendix A  Summary of data included in this report 
 
A1 Data summary 
During the reporting period, data were provided for a total of 19,220 patients who between them had 24,180 episodes of care and 55,991 palliative care phases. These 
total numbers are determined by a data scoping method. This method looks at the phase level data first and includes all phases that ended within the current reporting 
period. The associated episodes and patients are then determined (Appendix C contains a more detailed explanation of this process). Table 33 shows the number of 
patients, episodes and phases included in this report. 
 
 
Table 33  Number and percentage of patients, episodes and phases by setting 
 Inpatient Community Total 
Number of patients*   10,692    9,391 19,220 
Number of episodes   12,464   11,716 24,180 
Number of phases**   29,459   26,532 55,991 
Percentage of patients*     55.6     48.9 100 
Percentage of episodes     51.5     48.5 100 
Percentage of phases     52.6     47.4 100 
Average number of  phases per episode*** 2.3 2.1 2.3 
*     Patients seen in both settings are only counted once in the total column and hence numbers/percentages may not add to the total. 
**   Bereavement phases are excluded from this count. 
***    Average number of phases per episode is only calculated for closed episodes that started and ended within the reporting period and excludes bereavement phases.  
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Table 34 shows the number of completed episodes and phases by setting for each month in the current reporting period. 
Table 34  Number of completed episodes and phases by month and setting 
   Jan Feb Mar Apr May Jun 
Inpatient 
No. of completed episodes 1,896 1,924 2,173 1,963 2,146 2,138 
No. of completed phases 4,906 4,666 5,354 4,726 5,105 4,702 
Community 
No. of completed episodes 1,727 1,675 1,829 1,747 1,749 1,748 
No. of completed phases 4,643 4,401 4,548 4,257 4,307 4,376 
 
 
Table 35 shows the number of patients, episodes and phases over time and is reported by setting of care. 
Table 35  Number of patients, episodes and phases by setting and reporting period 
 
Inpatient Community 
Jul-Dec 
2012  
Jan-Jun 
2013  
Jul-Dec 
2013  
Jan-Jun 
2014  
Jul-Dec 
2014  
Jan-Jun 
2015  
Jul-Dec 
2012  
Jan-Jun 
2013  
Jul-Dec 
2013  
Jan-Jun 
2014  
Jul-Dec 
2014  
Jan-Jun 
2015  
Number of patients* 9,628 9,737 9,646 9,502 10,311 10,692 7,700 7,546 8,541 8,206 8,963 9,391 
Number of episodes 11,279 11,423 11,407 11,279 12,224 12,464 9,397 9,280 10,579 10,204 11,225 11,716 
Number of phases** 26,848 26,875 28,359 26,013 28,409 29,459 19,621 19,500 22,961 22,567 25,058 26,532 
Average number of  
phases per episode*** 2.4 2.4 2.5 2.3 2.3 2.3 1.9 2.0 2.0 2.1 2.0 2.1 
*     Patients seen in both settings are only counted once in the total column and hence numbers/percentages may not add to the total. 
**   Bereavement phases are excluded from this count. 
***    Average number of phases per episode is only calculated for closed episodes that started and ended within the reporting period and excludes bereavement phases.  
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A2 Data item completion 
As shown in Table 36, Table 37 and Table 38 below, the rate of data completion is very high.  In reviewing these tables, it is important to note that in some cases some 
data items are not required to be completed. For example, place of death is only required for patients who have died. Hence the complete column in the following tables 
only refers to the percentage of complete records where the data item was relevant. 
 
PCOC strongly encourages services to complete and submit the whole data set on every patient as non-completion may result in services being excluded from relevant 
benchmarking activities or erroneous conclusions being drawn. Low completion of data items may also distort percentages and graphs in some sections. 
 
 
 
 
  
Table 36  Item completion (per cent complete) - 
patient level 
Data item Total 
Date of birth 100.0 
Sex 100.0 
Indigenous status 97.9 
Country of birth 98.5 
Preferred language 99.2 
Primary diagnosis 99.6 
Note: This table is not split by setting to be consistent with 
the patient level analysis throughout this report. 
Table 37  Item completion by setting (per cent complete) - episode level 
Data item Inpatient Community Total 
Date of first contact 98.9 100.0 99.4 
Referral date 98.9 100.0 99.4 
Referral source 99.9 99.7 99.8 
Date ready for care 95.6 99.9 97.7 
Mode of episode start 99.9 99.5 99.7 
Accommodation at episode start 99.9 96.6 97.9 
Episode end date* 99.8 94.0 97.0 
Mode of episode end 99.9 99.8 99.9 
Accommodation at episode end 99.3 89.9 96.8 
Place of death na 94.4 94.4 
* Episode end date item completion may be affected by open episodes. 
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Table 38  Item completion by setting (per cent complete) - phase level 
Data item 
Sub-Category  At phase start At discharge 
(where applicable) Inpatient Community Total Inpatient Community Total 
RUG-ADL 
Bed mobility 99.7 96.9 98.3 91.4 60.9 73.6 
Toileting 99.7 96.7 98.3 91.3 60.9 73.6 
Transfers 99.7 96.5 98.2 91.3 60.8 73.6 
Eating 99.4 95.8 97.7 91.3 60.6 73.4 
PCPSS 
  
Pain 99.1 96.9 98.1 91.0 60.4 73.2 
Other symptom 97.4 95.0 96.2 90.0 59.7 72.3 
Psychological / spiritual 99.3 96.2 97.9 91.0 60.1 73.0 
Family / carer 98.0 95.3 96.7 87.7 59.9 71.5 
SAS 
   
Difficulty sleeping 93.9 92.9 93.4 79.6 57.2 66.6 
Appetite problems 94.1 95.1 94.6 80.2 59.3 68.0 
Nausea 94.1 96.2 95.1 79.6 60.0 68.2 
Bowel problems 94.0 95.2 94.5 80.1 58.9 67.8 
Breathing problems 94.2 95.6 94.8 79.9 59.5 68.0 
Fatigue 94.1 96.2 95.1 80.5 60.2 68.7 
Pain 94.2 97.4 95.7 80.5 61.0 69.1 
AKPS   - 95.1 97.3 96.1 89.4 63.0 74.1 
 
Data item Inpatient Community Total 
Phase End Reason 99.9 99.5 99.7 
  
     
 National Report on Patient Outcomes in Palliative Care in Australia, January - June 2015 45 
Appendix B Additional information on profile of SAS and PCPSS  
Figure 21  Profile of SAS and PCPSS by phase type – inpatient setting 
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Figure 22  Profile of SAS and PCPSS by phase type – community setting 
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Appendix C Data scoping method 
 
The method used to determine which data is included in a PCOC report looks at the phase level records first. All phase records that end within the 6 month reporting 
period are deemed to be “in scope” and would be included in the report. The episode and patient records associated with these phases are also deemed to be “in scope” 
and hence would also be included in the report. Figure 23 below displays four examples to help visualize this process. 
 
Figure 23  Diagram of the PCOC data scoping method 
 
 
In Example 1, the patient (represented by the green line) has one episode (represented by the blue line). This episode has six phases (represented by the purple line 
segments). All six phases would be included in the report as they all end within the reporting period. Hence, the episode and patient would also be in the report. 
 
In Example 2, the patient has two episodes - the first having six phases and the second having seven phases. Looking at the phases associated with the first episode, the 
last four will be included in the report (as they end within the reporting period). The first two phases would have been included in the previous report. For the phases 
relating to the second episode, only the first three end within the reporting period, so only these would be included in the report. The following four phases would be 
included in the next report. Both of the episode records and the patient record would also be included in the report.  
 
In Example 3, the patient has one episode and five phases. Only the last three phases will be included in the report as they are the only ones ending within the reporting 
period (the first two phases would have been included in the previous report). The episode and patient records would be included in the report. 
 
In Example 4, the patient again has one episode and five phases. This time, only the first three phases will be included in the report (the last two phases will be included 
in the next report). Again, the episode and patient records would be included in the report. 
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Appendix D Palliative Care Phase definitions 
START END 
1. Stable 
Patient problems and symptoms are adequately controlled by established plan of care 
and 
 Further interventions to maintain symptom control and quality of life have been 
planned and 
 Family / carer situation is relatively stable and no new issues are apparent. 
The needs of the patient and / or family / carer increase, requiring changes to 
the existing plan of care. 
2. Unstable 
An urgent change in the plan of care or emergency treatment is required because 
 Patient experiences a new problem that was not anticipated in the existing plan of 
care, and / or 
 Patient experiences a rapid increase in the severity of a current problem; and / or 
 Family / carers circumstances change suddenly impacting on patient care. 
 The new plan of care is in place, it has been reviewed and no further 
changes to the care plan are required. This does not necessarily mean that 
the symptom / crisis has fully resolved but there is a clear diagnosis and 
plan of care (i.e. patient is stable or deteriorating) and / or 
 Death is likely within days (i.e. patient is now terminal). 
3. Deteriorating 
The care plan is addressing anticipated needs but requires periodic review because 
 Patients overall functional status is declining and 
 Patient experiences a gradual worsening of existing problem and / or 
 Patient experiences a new but anticipated problem and / or 
 Family / carers experience gradual worsening distress that impacts on the patient 
care. 
 Patient condition plateaus (i.e. patient is now stable) or 
 An urgent change in the care plan or emergency treatment and / or 
 Family / carers experience a sudden change in their situation that impacts 
on patient care, and urgent intervention is required (i.e. patient is now 
unstable) or 
 Death is likely within days (i.e. patient is now terminal). 
4. Terminal 
Death is likely within days.  Patient dies or 
 Patient condition changes and death is no longer likely within days (i.e. 
patient is now stable or deteriorating). 
5. Bereavement – post death support 
 The patient has died 
 Bereavement support provided to family / carers is documented in the deceased 
patient’s clinical record. 
 Case closure 
Note: If counselling is provided to a family member or carer, they become a 
client in their own right. 
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